Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults
- Conditions
- Interventions
- First Posted Date
- 2013-06-27
- Last Posted Date
- 2022-05-31
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 144
- Registration Number
- NCT01887522
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
🇨🇭Swiss Pediatric Oncology Group, Bern, Switzerland
🇬🇧Cancer Research UK Clinical Trials Unit School of Cancer Sciences University of Birmingham, Edgbaston, Birmingham, United Kingdom
Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer
- First Posted Date
- 2013-06-27
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 61
- Registration Number
- NCT01888042
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val de Marne, France
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
- First Posted Date
- 2013-06-26
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 271
- Registration Number
- NCT01887340
- Locations
- 🇫🇷
Gustave Roussy, Villejuif, Val de Marne, France
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 82
- Registration Number
- NCT01884623
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults
- Conditions
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 35
- Registration Number
- NCT01884922
- Locations
- 🇨🇭
Swiss Pediatric Oncology Group, Bern, Switzerland
🇳🇱Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
🇬🇧Cancer Research UK Clinical Trials Unit School of Cancer Sciences University of Birmingham, Edgbaston, Birmingham, United Kingdom
A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies
- First Posted Date
- 2013-05-17
- Last Posted Date
- 2019-06-18
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 303
- Registration Number
- NCT01856296
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
- Conditions
- Interventions
- First Posted Date
- 2013-04-23
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 776
- Registration Number
- NCT01837745
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Identification of Early Markers of Response and Resistance to Trastuzumab
- Conditions
- Interventions
- First Posted Date
- 2013-04-18
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 25
- Registration Number
- NCT01834950
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val De Marne, France
Peripheral Primitive Fibromatosis
- First Posted Date
- 2013-02-28
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 100
- Registration Number
- NCT01801176
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val de Marne, France
Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
- Conditions
- Interventions
- First Posted Date
- 2013-02-07
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 55
- Registration Number
- NCT01786031
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, Val de Marne, France